Vancouver Biotech (Canada)
In research, Vancouver Biotech (Canada) stands highest in Social Sciences (#10,323 of 16,945 worldwide), Health Sciences (#16,297 of 20,462 worldwide) and Medicine (#14,748 of 17,978 worldwide), over all time.
- World rank, 2022–2025
- #21,664 of 28,054 · #14,924 all time
- Rank in Canada
- #342 of 403
- Research works
- 499 ▲ 45% vs 2013–17
- Citations
- 7.7k 15.4 per fractional work
- Top-10% rate
- 7.2% record average 16.5%
- Open access
- 49% world 28%
What is Vancouver Biotech (Canada) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Social SciencesDomain | #10,323 of 16,945 | 10.1% | 121 | |
| Health SciencesDomain | #16,297 of 20,462 | 8.2% | 191 | |
| MedicineField | #14,748 of 17,978 | 7.9% | 165 |
Each strip is that field’s whole ranked pool, with the notch where Vancouver Biotech (Canada) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.6×. Every wedge is a field page.
- Immunology and Microbiology 3.6×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Health Professions 1.1×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Neuroscience 0.9×
- Economics, Econometrics and Finance 0.5×
- Psychology 0.4×
- Agricultural and Biological Sciences 0.4×
- Social Sciences 0.2×
- Business, Management and Accounting 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Materials Science 0.1×
- Environmental Science 0.1×
- Earth and Planetary Sciences 0.1×
Who are the top researchers at Vancouver Biotech (Canada)?
Ranked on the composite score, Heather Kent lead among researchers whose main affiliation is Vancouver Biotech (Canada).
- 1 Heather Kent · #1,190,056 worldwide 4 citations · 27 works
Which keywords describe research at Vancouver Biotech (Canada)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Epidemiology, Genetic Mutations, Gene Therapy, Radiotherapy, Radiosurgery, Prognosis and Surgical Management.
- Cognitive Impairment
- Tumor Suppressor
- Guideline Development
- Quality Assessment
- Epilepsy
- Diagnostic Criteria
- Glioblastoma
- Neuroprotection
- Tumor Regression
- Pathogenesis
- Viral Vectors
- Meningiomas
- AAV
- Treatment
- Autoantibodies
- Prognostic Factors
- Surgical Management
- Radiosurgery
- Gene Therapy
- Immunotherapy
- Epidemiology
- Genetic Mutations
- Radiotherapy
- Prognosis
- Neurological Disorders
- Inflammation
- Public Health
- Genomic Analysis
- Histological Classification
- Vaccine
- Diagnosis
- Immune Response
- Molecular Classification
- Clinical Management
- Temozolomide
- Endovascular Treatment
- Intravenous Immunoglobulin
- Clinical Guidelines
- Neurofibromatosis
- Antiepileptic Drugs
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 3.7×24 topics
- Immunotherapy9▲ 15×8 topics
- Genetic Mutations7▲ 18×7 topics
- Gene Therapy6▲ 36×3 topics
- Radiotherapy6▲ 17×5 topics
- Radiosurgery5▲ 69×3 topics
- Prognosis5▲ 18×5 topics
- Surgical Management5▲ 14×5 topics
- Neurological Disorders5▲ 10.0×8 topics
- Prognostic Factors4▲ 12×2 topics
- Inflammation4▲ 2.2×8 topics
- Autoantibodies4▲ 19×5 topics
- Public Health4▲ 3.0×8 topics
- Treatment4▲ 3.5×9 topics
- Genomic Analysis4▲ 17×2 topics
- AAV3▲ 94×1 topic
- Histological Classification3▲ 124×1 topic
- Meningiomas3▲ 124×1 topic
- Vaccine3▲ 9.2×5 topics
- Viral Vectors3▲ 94×1 topic
- Diagnosis3▲ 3.6×7 topics
- Pathogenesis3▲ 6.8×4 topics
- Immune Response3▲ 5.7×4 topics
- Tumor Regression3▲ 29×2 topics
- Molecular Classification3▲ 20×2 topics
- Neuroprotection3▲ 8.7×3 topics
- Clinical Management2▲ 17×4 topics
- Glioblastoma2▲ 43×1 topic
- Temozolomide2▲ 43×1 topic
- Diagnostic Criteria2▲ 12×4 topics
- Endovascular Treatment2▲ 44×2 topics
- Epilepsy2▲ 24×2 topics
- Intravenous Immunoglobulin2▲ 39×2 topics
- Quality Assessment2▲ 14×2 topics
- Clinical Guidelines2▲ 8.6×1 topic
- Guideline Development2▲ 121×1 topic
- Neurofibromatosis2▲ 125×1 topic
- Tumor Suppressor2▲ 61×1 topic
- Antiepileptic Drugs2▲ 31×2 topics
- Cognitive Impairment2▲ 9.3×4 topics
Which research topics does Vancouver Biotech (Canada) publish most on?
By volume in 2022–2025: Meningioma and schwannoma management, Virus-based gene therapy research, Glioma Diagnosis and Treatment and Clinical practice guidelines implementation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Meningioma and schwannoma management Epidemiology 3 works
- 2 Virus-based gene therapy research Genetics 3 works
- 3 Glioma Diagnosis and Treatment Genetics 2 works
- 4 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 2 works
- 5 Neurofibromatosis and Schwannoma Cases Neurology 2 works
- 6 Epilepsy research and treatment Psychiatry and Mental health 2 works
- 7 Cancer Research and Treatments Biotechnology 2 works
- 8 Vascular Malformations Diagnosis and Treatment Neurology 2 works
- 9 Trauma and Emergency Care Studies Emergency Medicine 2 works
- 10 Peripheral Neuropathies and Disorders Neurology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Vancouver Biotech (Canada)'s research output changed?
Output in 2018–2022 was 45% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Vancouver
- University of British Columbia
- BC Cancer Agency
- BC Children's Hospital
- Vancouver General Hospital
- TRIUMF
- St. Paul's Hospital
- University of British Columbia Hospital
- Women's Health Research Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.